Literature DB >> 34901777

Don't "Waive" Goodbye to Education for Opioid Use Disorder.

Richard Bottner1, Jeffrey Bratberg2, Marlene Martin3, Melissa B Weimer4, Ayana Jordan4, Matthew Tierney5.   

Abstract

Entities:  

Year:  2021        PMID： 34901777      PMCID： PMC8654468          DOI： 10.31478/202110b

Source DB:  PubMed          Journal:  NAM Perspect        ISSN： 2578-6865


× No keyword cloud information.
  10 in total

1.  Buprenorphine Treatment Divide by Race/Ethnicity and Payment.

Authors:  Pooja A Lagisetty; Ryan Ross; Amy Bohnert; Michael Clay; Donovan T Maust
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

2.  Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.

Authors:  Christopher M Jones; Elinore F McCance-Katz
Journal:  Addiction       Date:  2018-10-15       Impact factor: 6.526

3.  Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration.

Authors:  Adam J Gordon; Greg Kavanagh; Margaret Krumm; Rajeev Ramgopal; Sanjay Paidisetty; Minu Aghevli; Francine Goodman; Jodie Trafton; Joseph Liberto
Journal:  Psychol Addict Behav       Date:  2011-06

4.  Specific disciplines addressing substance use: AMERSA in the 21st century.

Authors:  Beth A Rutkowski
Journal:  Subst Abus       Date:  2019-11-20       Impact factor: 3.716

5.  Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.

Authors:  Rebecca L Haffajee; Amy S B Bohnert; Pooja A Lagisetty
Journal:  Am J Prev Med       Date:  2018-06       Impact factor: 5.043

6.  Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.

Authors:  C Holly A Andrilla; Tessa E Moore; Davis G Patterson
Journal:  J Rural Health       Date:  2018-10-19       Impact factor: 4.333

7.  Opioid Treatment Deserts: Concept development and application in a US Midwestern urban county.

Authors:  Ayaz Hyder; Jinhyung Lee; Ashley Dundon; Lauren T Southerland; David All; Gretchen Hammond; Harvey J Miller
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

8.  It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiver.

Authors:  Brendan Saloner; Barbara Andraka Christou; Adam J Gordon; Bradley D Stein
Journal:  Subst Abus       Date:  2021-04-02       Impact factor: 3.716

Review 9.  Core competencies for pain management: results of an interprofessional consensus summit.

Authors:  Scott M Fishman; Heather M Young; Ellyn Lucas Arwood; Roger Chou; Keela Herr; Beth B Murinson; Judy Watt-Watson; Daniel B Carr; Debra B Gordon; Bonnie J Stevens; Debra Bakerjian; Jane C Ballantyne; Molly Courtenay; Maja Djukic; Ian J Koebner; Jennifer M Mongoven; Judith A Paice; Ravi Prasad; Naileshni Singh; Kathleen A Sluka; Barbara St Marie; Scott A Strassels
Journal:  Pain Med       Date:  2013-04-11       Impact factor: 3.750

10.  Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US.

Authors:  Alexandra Duncan; Jared Anderman; Travis Deseran; Ian Reynolds; Bradley D Stein
Journal:  JAMA Netw Open       Date:  2020-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.